Clinical Trial

Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer

Name: Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer — clinical trial record (NCT07233863)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.

Trial Details

NCT Number	NCT07233863
Lead Sponsor	Dharmais National Cancer Center Hospital
Conditions	Lymphedema Arm
Enrollment	136 participants
Start Date	2024-03-18
Primary Completion	2027-03-21 (estimated)
Study Completion	2028-03-21 (estimated)
Updated on ClinicalTrials.gov	2025-11-18